Intimation for Closure of Trading Window for Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2025.
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare Limited has informed BSE that its trading window will remain closed for all Directors, Insiders, Designated Employees, and their immediate relatives starting January 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and nine months ended December 31, 2025. This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, aimed at preventing trading in the company's securities while unpublished price-sensitive information (quarterly results) is pending. The exact board meeting date to approve these results has not yet been disclosed and will be communicated later.
This is a standard regulatory filing and does not directly impact shareholders. However, it signals that Bilcare's Q3 FY26 results are likely to be announced in early-to-mid January 2026, and no insider trades can occur during this blackout period. Investors should watch for the upcoming results announcement for any business performance updates.